Carson Wealth (CWM LLC)
TRVI icon

Carson Wealth (CWM LLC)’s Trevi Therapeutics TRVI Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.06K Buy
424
+43
+11% +$481 ﹤0.01% 5020
2025
Q4 		$5K Buy
381
+17
+5% +$196 ﹤0.01% 4846
2025
Q3 		$3K Buy
364
+135
+59% +$1.01K ﹤0.01% 4949
2025
Q2 		$1K Buy
229
+94
+70% +$585 ﹤0.01% 5082
2025
Q1 		$1K Buy
135
+53
+65% +$253 ﹤0.01% 4998
2024
Q4 		$0 Sell
82
-4
-5% -$13 ﹤0.01% 5170
2024
Q3 		$0 Buy
86
+53
+161% +$158 ﹤0.01% 5153
2024
Q2 		$0 Buy
33
+30
+1,000% +$83 ﹤0.01% 4947
2024
Q1 		$0 Buy
+3
New +$7 ﹤0.01% 4750

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Carson Wealth (CWM LLC)'s TRVI Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Trevi Therapeutics (TRVI) stake by 11% in Q1 2026, buying an estimated $481 and bringing the position to 424 shares worth $5.06K. The position accounts for ﹤0.01% of the portfolio, ranked #5020.

Carson Wealth (CWM LLC) first reported a position in TRVI in Q1 2024 and has held it in 9 quarters since. 198 funds tracked by Wall St. Rank hold TRVI as of Q1 2026.

  • Carson Wealth (CWM LLC) held 424 shares of Trevi Therapeutics worth $5.06K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 43 Trevi Therapeutics shares in Q1 2026, an estimated $481.
  • Trevi Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5020 holding.
  • Carson Wealth (CWM LLC) first reported a position in Trevi Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • 198 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.